20 articles
Industry leaders at Milan 2026 say longevity medicine must move beyond hype and deliver measurable, accountable preventive care.
Elysium Health moves beyond supplements into integrated longevity medicine, bundling prescriptions, peptides, and clinical monitoring for 10,000 members.
Dr Poonam Desai argues that personalized medicine rings hollow while clinical frameworks still use male biology as the default standard.
China's first standardized longevity medicine curriculum trains doctors in aging biology, cardiometabolic prevention, and AI-assisted care.
Immorta Bio is using AI to move beyond disease treatment toward restoring youthful biology by clearing senescent cells and reviving stem cells.
China introduces a structured national curriculum training doctors in healthspan, aging biology, AI diagnostics, and preventive care.
From an $80M genetics study to a single-injection heart therapy, new research is redefining what drives exceptional human lifespan.
Insilico Medicine's new AI-powered Longevity Board aims to develop drugs that slow biological aging, not just treat individual diseases.
Immorta Bio combines senolytics and stem cell revival with AI to achieve 70%+ lifespan extension in animal models.
A new global report finds longevity clinics are scaling fast but lack the standardized frameworks needed to validate their outcomes.
Insilico Medicine assembles top scientists and a Nobel laureate to guide AI-driven aging research and translate longevity compounds into real medicines.
New startup combines home testing, house calls, and physician-led care to streamline men's longevity healthcare in one integrated platform.
Geroscience pioneer Dr Nir Barzilai explains how intervening in aging biology — not individual diseases — may be medicine's biggest leap.
An $80M renewal of the Long Life Family Study uncovers genes, proteins, and fitness traits that predict exceptional longevity.
Swiss partnership launches cellular avatars that predict immune responses and aging patterns using AI-powered modeling.
WashU Medicine's Long Life Family Study renewal uses long-read sequencing to decode why some families consistently escape age-related disease.
A new wave of biotechs is targeting aging as a root cause, using encapsulated cells and gene therapy to restore lost proteins and reverse decline.
From AI-ready drug datasets to GLP-1s as longevity drugs, 2025's biggest aging science shifts are reshaping the field.
New genetic and proteomic findings from centenarian studies uncover biological markers that distinguish the longest-lived humans from the rest of us.
An $80M family study, 37 proteins in centenarian blood, and a call to treat aging as a systems failure converge in new research.
